findmyKOL
Clinical trialNCT02520388CompletedPhase 3Interventional

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

SponsorIronshore Pharmaceuticals and Development, IncEnrollment163Attention Deficit Hyperactivity Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Avida

    Newport Beach, California, United States

  • Florida Clinical Research Center, Llc

    Bradenton, Florida, United States

  • Sarkis Clinical Trials

    Gainesville, Florida, United States

  • Clinical Neuroscience Solutions, Inc

    Jacksonville, Florida, United States

  • Florida Clinical Research Center, Llc

    Maitland, Florida, United States

  • Scientific Clinical Research, Inc.

    North Miami, Florida, United States

  • Medical Research Group of Central Florida

    Orange City, Florida, United States

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida, United States

  • Qps Mra, Dba Miami Research Associates, Llc

    South Miami, Florida, United States

  • Children'S Developmental Center, P.A.

    Winter Park, Florida, United States

  • Pedia Research, Llc

    Owensboro, Kentucky, United States

  • Duke University Medical Center, Duke Child and Family Study Center

    Durham, North Carolina, United States

  • Cutting Edge Research Group

    Oklahoma City, Oklahoma, United States

  • Ips Research Company

    Oklahoma City, Oklahoma, United States

  • Clinical Neuroscience Solutions, Inc.

    Memphis, Tennessee, United States

  • Bayou City Research, Ltd

    Houston, Texas, United States

  • Red Oak Psychiatry Associates, Pa

    Houston, Texas, United States

  • Westex Clinical Investigations

    Lubbock, Texas, United States

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas, United States

  • Ericksen Research and Development

    Clinton, Utah, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2015
Primary completion
30 Apr 2016
Completion
31 May 2016
Last update posted
23 Jul 2021
Registered enrollment
163
Registry id
NCT02520388

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.